Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

MYC Expression Is Prognostic in Therapy Related Acute Myeloid Leukemia (AML) and AML with Myelodysplastic Syndrome (MDS)-Related Changes

Maro Ohanian, DO, Uri Rozovski, MD, Hagop M. Kantarjian, MD, Sanam Loghavi, MD, Yang O. Huh, MD, Lynne Abruzzo, MDPhD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MD, Michael Andreeff, MD PhD, Steven M. Kornblau, MD, Gautam Borthakur, MD, Martin Nguyen, BS, Francesco Stingo, PhD, Peter Hu, Patricia Fox, MS, L. Jeffrey Medeiros, MD, Zeev Estrov, MD, Carlos E. Bueso-Ramos, MD PhD, Jorge E. Cortes, MD

Blood (2014) 124 (21): 5334.

https://doi.org/10.1182/blood.V124.21.5334.5334

Published: 2014

Journal Articles

The Heterogeneous Prognosis of Patients with Myelodysplastic Syndrome (MDS) and Chromosome 5 Abnormalities: How Does It Relate to the Original Lenalidomide Experience in MDS?.

Hagop M Kantarjian, Susan O’Brien, Farhad Ravandi, Gautam Borthakur, Stefan Faderl, Carlos Bueso-Ramos, Lynne Abruzzo, Sherry Pierce, Jianqin Shan, Jean-Pierre Issa, Guillermo Garcia-Manero

Blood (2008) 112 (11): 1644.

https://doi.org/10.1182/blood.V112.11.1644.1644

Published: 2008

Journal Articles

Myelodysplastic Syndromes and Acute Myeloid Leukemia with t(6;9)(p23;q34).

John Delmonte, Jr., MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Gautam Borthakur, MD, Francis J. Giles, MD, Lynne Abruzzo, MD, Sherry Pierce, Jorge Cortes, MD

Blood (2007) 110 (11): 3502.

https://doi.org/10.1182/blood.V110.11.3502.3502

Published: 2007

Journal Articles

The Clinical Usefulness of Novel Prognostic Factors in CLL: A Study of 477 Patients with Low-Risk (Non-11q, Non-17p) FISH and Known IGVH Mutation Status.

Constantine S. Tam, MBBS, Michael J. Keating, MD, Apostolia M. Tsimberidou, MD, Susan O’Brien, MD, Alessandra Tsimberidou, MD, Susan Lerner, MS, Lynne Abruzzo, MD, Ellen Schlette, MD, Hagop Kantarjian, MD, William Wierda, MD

Blood (2007) 110 (11): 3079.

https://doi.org/10.1182/blood.V110.11.3079.3079

Published: 2007

Journal Articles

Chromosomal Abnormalities in Philadelphia Chromosome (Ph)-Negative Metaphases Appearing during Novel Tyrosine Kinase Inhibitors (NTKI) Therapy in Patients (pts) with Chronic Myeloid Leukemia (CML) after Imatinib-Failure.

Elias Jabbour, MD, Hagop Kantarjian, MD, Lynne Abruzzo, MD, Francis Giles, MD, Mary Beth Rios, RN, Jorge Cortes, MD

Blood (2006) 108 (11): 2115.

https://doi.org/10.1182/blood.V108.11.2115.2115

Published: 2006

Journal Articles

Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate

Elias Jabbour, Hagop Kantarjian, Susan O'Brien, Mary Beth Rios, Lynne Abruzzo, Srdan Verstovsek, Guillermo Garcia-Manero, Jorge Cortes

Blood (2006) 107 (2): 480–482.

https://doi.org/10.1182/blood-2005-05-1816

Published: 2006

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

MYC Expression Is Prognostic in Therapy Related Acute Myeloid Leukemia (AML) and AML with Myelodysplastic Syndrome (MDS)-Related Changes

The Heterogeneous Prognosis of Patients with Myelodysplastic Syndrome (MDS) and Chromosome 5 Abnormalities: How Does It Relate to the Original Lenalidomide Experience in MDS?.

Myelodysplastic Syndromes and Acute Myeloid Leukemia with t(6;9)(p23;q34).

The Clinical Usefulness of Novel Prognostic Factors in CLL: A Study of 477 Patients with Low-Risk (Non-11q, Non-17p) FISH and Known IGVH Mutation Status.

Chromosomal Abnormalities in Philadelphia Chromosome (Ph)-Negative Metaphases Appearing during Novel Tyrosine Kinase Inhibitors (NTKI) Therapy in Patients (pts) with Chronic Myeloid Leukemia (CML) after Imatinib-Failure.

Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate

Email alerts

ASH Publications

American Society of Hematology

Update search

MYC Expression Is Prognostic in Therapy Related Acute Myeloid Leukemia (AML) and AML with Myelodysplastic Syndrome (MDS)-Related Changes

The Heterogeneous Prognosis of Patients with Myelodysplastic Syndrome (MDS) and Chromosome 5 Abnormalities: How Does It Relate to the Original Lenalidomide Experience in MDS?.

Myelodysplastic Syndromes and Acute Myeloid Leukemia with t(6;9)(p23;q34).

The Clinical Usefulness of Novel Prognostic Factors in CLL: A Study of 477 Patients with Low-Risk (Non-11q, Non-17p) FISH and Known IGVH Mutation Status.

Chromosomal Abnormalities in Philadelphia Chromosome (Ph)-Negative Metaphases Appearing during Novel Tyrosine Kinase Inhibitors (NTKI) Therapy in Patients (pts) with Chronic Myeloid Leukemia (CML) after Imatinib-Failure.

Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only